Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression

Journal of Affective Disorders

Volumn 243, Issue , 2019, Pages 116-120

  Rosenblat, Joshua D ^a   Simon, Gregory E ^b,c   Sachs, Gary S ^b   Deetz, Ingrid ^b   Doederlein, Allen ^b   DePeralta, Denisse ^b   Dean, Mary Mischka ^b   McIntyre, Roger S ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b Depression and Bipolar Support Alliance (DBSA)   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

adverse effects; bipolar disorder; cognition; major depressive disorder; patient reported outcomes (PROs); Patient centred outcomes; quality of life; remission; response; side effects; wellness, recovery

Indexed keywords

ARTICLE; BIPOLAR DEPRESSION; BODY WEIGHT GAIN; COMPARATIVE STUDY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL HEALTH ORGANIZATION; MENTAL PATIENT; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SATISFACTION; PATIENT-REPORTED OUTCOME; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; ADULT; BIPOLAR DISORDER; FEMALE; MALE; PSYCHOLOGY; SELF REPORT; TREATMENT OUTCOME;

PSYCHOTROPIC AGENT;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; PATIENT REPORTED OUTCOME MEASURES; PSYCHOTROPIC DRUGS; QUALITY OF LIFE; SELF REPORT; TREATMENT OUTCOME;

EID: 85053559155     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2018.09.027     Document Type: Article

References (23)

1. Ahmed, S., Berzon, R.A., Revicki, D.A., Lenderking, W.R., Moinpour, C.M., Basch, E., Research, on behalf of the I. S. for Q. of L. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Medical Care, 50(12), 2012, 1060 https://doi.org/10.1097/MLR.0b013e318268aaff.
2. Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Rose, M., The patient-reported outcomes measurement information system (PROMIS). Medical Care 45:5 Suppl 1 (2007), S3–S11 https://doi.org/10.1097/01.mlr.0000258615.42478.55.
3. Cipriani, A., Furukawa, T.A., Salanti, G., Chaimani, A., Atkinson, L.Z., Ogawa, Y., Geddes, J.R., Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 0(0), 2018 https://doi.org/10.1016/S0140-6736(17)32802-7.
4. from http://www.dbsalliance.org/site/PageServer?pagename=help_surveycenter, 2018.
5. Fava, M., Rush, A.J., Alpert, J.E., Balasubramani, G.K., Wisniewski, S.R., Carmin, C.N., Trivedi, M.H., Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. The Am. J. Psychiatry 165 (2008), 342–351 https://doi.org/10.1176/appi.ajp.2007.06111868.
6. Flynn, K.E., Kramer, J.M., Dombeck, C.B., Weinfurt, K.P., Participants’ perspectives on safety monitoring in clinical trials. Clinical Trials 10:4 (2013), 552–559 https://doi.org/10.1177/1740774513484394.
7. Gaynes, B.N., Warden, D., Trivedi, M.H., Wisniewski, S.R., Fava, M., Rush, A.J., What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr. Serv. 60 (2009), 1439–1445 https://doi.org/10.1176/appi.ps.60.11.1439.
8. Grande, I., Berk, M., Birmaher, B., Vieta, E., Bipolar disorder. Lancet 387 (2016), 1561–1572 https://doi.org/10.1016/S0140-6736(15)00241-X.
9. IsHak, W.W., Greenberg, J.M., Balayan, K., Kapitanski, N., Jeffrey, J., Fathy, H., Rapaport, M.H., Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv. Rev. Psychiatry 19:5 (2011), 229–239 https://doi.org/10.3109/10673229.2011.614099.
10. McIntyre, R.S., Soczynska, J.K., Cha, D.S., Woldeyohannes, H.O., Dale, R.S., Alsuwaidan, M.T., Kennedy, S.H., The prevalence and illness characteristics of DSM-5-defined “mixed feature specifier” in adults with major depressive disorder and bipolar disorder: results from the International Mood Disorders Collaborative Project. J. Affect. Disord 172 (2015), 259–264 https://doi.org/10.1016/j.jad.2014.09.026.
11. Murnane, E.L., Cosley, D., Chang, P., Guha, S., Frank, E., Gay, G., Matthews, M., Self-monitoring practices, attitudes, and needs of individuals with bipolar disorder: implications for the design of technologies to manage mental health. J. Am. Med. Inform. Assoc. JAMIA 23:3 (2016), 477–484 https://doi.org/10.1093/jamia/ocv165.
12. Samalin, L., de Chazeron, I., Vieta, E., Bellivier, F., Llorca, P.-M., Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder. Bipolar Disord. 18:2 (2016), 164–173 https://doi.org/10.1111/bdi.12376.
13. Shimizu, Y., Kitagawa, N., Mitsui, N., Fujii, Y., Toyomaki, A., Hashimoto, N., Kusumi, I., Neurocognitive impairments and quality of life in unemployed patients with remitted major depressive disorder. Psychiatry Res 210 (2013), 913–918 https://doi.org/10.1016/j.psychres.2013.08.030.
14. Simon, G.E., Specht, C., Doederlein, A., Coping with suicidal thoughts: a survey of personal experience. Psychiatr. Serv. (Washington, D.C.) 67:9 (2016), 1026–1029 https://doi.org/10.1176/appi.ps.201500281.
15. Szmulewicz, A.G., Valerio, M.P., Smith, J.M., Samamé C., Martino, D.J., Strejilevich, S.A., Neuropsychological profiles of major depressive disorder and bipolar disorder during euthymia. A systematic literature review of comparative studies. Psychiatry Res. 248 (2017), 127–133 https://doi.org/10.1016/j.psychres.2016.12.031.
16. Valderas, J.M., Kotzeva, A., Espallargues, M., Guyatt, G., Ferrans, C.E., Halyard, M.Y., Alonso, J., The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Quality Life Res. 17:2 (2008), 179–193 https://doi.org/10.1007/s11136-007-9295-0.
17. Velligan, D.I., Weiden, P.J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., Docherty, J.P., Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. J. Psychiatr. Pract. 16:5 (2010), 306–324 https://doi.org/10.1097/01.pra.0000388626.98662.a0.
18. Wells, K.B., Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am. J. Psychiatry 156:1 (1999), 5–10 https://doi.org/10.1176/ajp.156.1.5.
19. WHO. (2017). Depression Fact Sheet.
20. Woo, Y.S., Rosenblat, J.D., Kakar, R., Bahk, W.-M., McIntyre, R.S., Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients. Clin. Psychopharmacol. Neurosci. 14:1 (2016), 1–16 https://doi.org/10.9758/cpn.2016.14.1.1.
21. Zimmerman, M., Martinez, J.A., Attiullah, N., Friedman, M., Toba, C., Boerescu, D.A., Rahgeb, M., Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission. J. Clin. Psychiatry 73:6 (2012), 790–795 https://doi.org/10.4088/JCP.11m07203.
22. Zimmerman, M., McGlinchey, J.B., Posternak, M.A., Friedman, M., Boerescu, D., Attiullah, N., Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: Implications for how remission from depression should be defined. Psychiatry Res. 141:2 (2006), 185–191 https://doi.org/10.1016/j.psychres.2005.05.016.
23. Zimmermann, T.M., Clouth, J., Elosge, M., Heurich, M., Schneider, E., Wilhelm, S., Wolfrath, A., Patient preferences for outcomes of depression treatment in Germany: a choice-based conjoint analysis study. J. Affect. Disord. 148:2–3 (2013), 210–219 https://doi.org/10.1016/j.jad.2012.11.062.